Initially, we extensively describe the rarest case, a patient diagnosed with chronic eosinophilic leukemia (CEL) with less than 1% bone marrow blasts associated with an NPM1 mutation who progressed to an acute myeloid leukemia (AML). This evidence concerns the gene NPM1 and acute myeloid leukemia.